Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunity.
Cell Rep
2024
43
11
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells.
Nat Commun
2024
15
1
A ONECUT1 regulatory, non-coding region in pancreatic development and diabetes.
Cell Rep
2024
43
11
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx.
JHEP Rep
2024
6
10
Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis.
Immunity
2025
58
1
124-142.e15
CDK4/6 inhibition initiates cell cycle arrest by nuclear translocation of RB and induces a multistep molecular response.
Cell Death Discov
2024
10
1
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma.
Nat Biomed Eng
2024
FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells.
Leukemia
2024
38
9
2027-2031
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification (vol 14, 4632, 2023)
Nat Commun
2024
15
1
Corrigendum to "A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer" [Bioorgan. Chem. 119 (2022) 105505].
Bioorg Chem
2024
146